Nearmap Ltd buy krebskrebs
Start price
22.02.21
/
50%
€1.69
Target price
22.02.22
€2.50
Performance (%)
-54.14%
End price
23.02.22
€0.78
Summary
This prediction ended on 23.02.22 with a price of €0.78. Massive losses of -54.14% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Nearmap Ltd | - | - | - | - |
iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
Comments by krebskrebs for this prediction
In the thread Nearmap Ltd diskutieren
Buy mit Kursziel 2,5
In the thread Trading Nearmap Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten